201 related articles for article (PubMed ID: 16627594)
1. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3.
Gao H; Bryzgalova G; Hedman E; Khan A; Efendic S; Gustafsson JA; Dahlman-Wright K
Mol Endocrinol; 2006 Jun; 20(6):1287-99. PubMed ID: 16627594
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
3. The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms.
Lundholm L; Bryzgalova G; Gao H; Portwood N; Fält S; Berndt KD; Dicker A; Galuska D; Zierath JR; Gustafsson JÅ; Efendic S; Dahlman-Wright K; Khan A
J Endocrinol; 2008 Nov; 199(2):X1. PubMed ID: 18757549
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
[TBL] [Abstract][Full Text] [Related]
5. miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3.
Xu L; Li Y; Yin L; Qi Y; Sun H; Sun P; Xu M; Tang Z; Peng J
Theranostics; 2018; 8(20):5593-5609. PubMed ID: 30555566
[TBL] [Abstract][Full Text] [Related]
6. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
Sajan MP; Ivey RA; Lee MC; Farese RV
J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
[TBL] [Abstract][Full Text] [Related]
7. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22.
Yang L; Zhang Y; Wang L; Fan F; Zhu L; Li Z; Ruan X; Huang H; Wang Z; Huang Z; Huang Y; Yan X; Chen Y
J Hepatol; 2010 Aug; 53(2):339-47. PubMed ID: 20452699
[TBL] [Abstract][Full Text] [Related]
9. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B; Reitman ML; Gonzalez FJ
J Clin Invest; 2003 Mar; 111(5):737-47. PubMed ID: 12618528
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.
Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E829-38. PubMed ID: 15941783
[TBL] [Abstract][Full Text] [Related]
11. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus.
Rahimian R; Masih-Khan E; Lo M; van Breemen C; McManus BM; Dubé GP
Mol Cell Biochem; 2001 Aug; 224(1-2):29-37. PubMed ID: 11693197
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.
Lan H; Rabaglia ME; Stoehr JP; Nadler ST; Schueler KL; Zou F; Yandell BS; Attie AD
Diabetes; 2003 Mar; 52(3):688-700. PubMed ID: 12606510
[TBL] [Abstract][Full Text] [Related]
13. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice.
Yahagi N; Shimano H; Hasty AH; Matsuzaka T; Ide T; Yoshikawa T; Amemiya-Kudo M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Nagai R; Ishibashi S; Yamada N
J Biol Chem; 2002 May; 277(22):19353-7. PubMed ID: 11923308
[TBL] [Abstract][Full Text] [Related]
14. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M
World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177
[TBL] [Abstract][Full Text] [Related]
15. Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice.
Gavito AL; Cabello R; Suarez J; Serrano A; Pavón FJ; Vida M; Romero M; Pardo V; Bautista D; Arrabal S; Decara J; Cuesta AL; Valverde AM; Rodríguez de Fonseca F; Baixeras E
Br J Pharmacol; 2016 Mar; 173(6):1070-84. PubMed ID: 26750868
[TBL] [Abstract][Full Text] [Related]
16. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.
Fromenty B; Vadrot N; Massart J; Turlin B; Barri-Ova N; Lettéron P; Fautrel A; Robin MA
J Pharmacol Exp Ther; 2009 Oct; 331(1):23-34. PubMed ID: 19587315
[TBL] [Abstract][Full Text] [Related]
17. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.
Collin de l'Hortet A; Zerrad-Saadi A; Prip-Buus C; Fauveau V; Helmy N; Ziol M; Vons C; Billot K; Baud V; Gilgenkrantz H; Guidotti JE
Endocrinology; 2014 Jul; 155(7):2545-54. PubMed ID: 24708244
[TBL] [Abstract][Full Text] [Related]
18. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
Sreejayan N; Dong F; Kandadi MR; Yang X; Ren J
Obesity (Silver Spring); 2008 Jun; 16(6):1331-7. PubMed ID: 18388893
[TBL] [Abstract][Full Text] [Related]
19. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.
Shimomura I; Matsuda M; Hammer RE; Bashmakov Y; Brown MS; Goldstein JL
Mol Cell; 2000 Jul; 6(1):77-86. PubMed ID: 10949029
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.
Zhang B; Graziano MP; Doebber TW; Leibowitz MD; White-Carrington S; Szalkowski DM; Hey PJ; Wu M; Cullinan CA; Bailey P; Lollmann B; Frederich R; Flier JS; Strader CD; Smith RG
J Biol Chem; 1996 Apr; 271(16):9455-9. PubMed ID: 8621615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
